In summary, we analyzed the difference in gene expression between CTC and PC3 cells and demonstrated that NDR1 expression decreased in prostate cancer cell that have strong metastatic ability, especially those with metastatic patients, showing correlation between decreased NDR1 and poor prognosis. This evidence concerns the gene STK38 and prostate cancer.